BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs4950928
,
GATA1
,
nitric oxide metabolic process
,
Ischemia
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NK- 1R
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for NK- 1R
Explore Curated Studies Results
Literature
Most Relevant Literature
Advances in the research and application of neurokinin-1 receptor antagonists.
Neurokinin-1 receptor antagonists for the prevention of postoperative nausea and vomiting.
Illuminating the structural basis of human neurokinin 1 receptor (NK1R) antagonism through classical…
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepit…
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Chall…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-head…
To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine…
Comparation Analgesia Efficiency With Propofol Combine Sevoflurane vs Propofol
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ